@prefix this: . @prefix sub: . @prefix np: . @prefix dct: . @prefix npx: . @prefix xsd: . @prefix orcid: . @prefix rdfs: . @prefix fip: . @prefix prov: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:ITN dct:isPartOf ; a fip:FAIR-Implementation-Community, fip:Mature-Community; rdfs:comment "The Immune Tolerance Network (ITN) is an international clinical research consortium sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. ITN's mission is to advance the clinical application of immune tolerance therapies and biomarker development by performing high quality clinical trials integrated with mechanism-based research with a focus on allergy, transplantation, and autoimmune disease."; rdfs:label "The Immune Tolerance Network (ITN) "; rdfs:seeAlso ; fip:has-description-source ; fip:has-research-domain , . } sub:provenance { sub:assertion dct:creator orcid:0000-0002-6396-0848 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCoKFb7LKlXyBB7BUvjFF9bDJNk0WxH3Xerr4H3v/VCiRVshEDl3BZVekbMMmdRe+TOPyc8AOLd9IAL2VfVVD/T0rmCHk7Pw7DQjI96mwyeXhE7f4g0WG5UT5Pxxm0Rzy7IrYnEaaVDs7dkZUt952M6qWlHfTwCQDcXJhZfLiXoMwIDAQAB"; npx:hasSignature "UgV5gmMCJPxnMCBwj3UN+7UL8D9zyrOQLtCndVLcHoyNX36bPGYWTrBMNBOhovPT54RyOacgRwpmgTQj55JDO55E6Ds697/ex5WBcdNdnlOryPOqviK+kNtE1sQjuL7KIWcS8IO/QgFnb0NJP/Wkdtr+kcox0WYU1t5Uc/Yg4Oo="; npx:hasSignatureTarget this: . this: dct:created "2025-01-30T10:38:49Z"^^xsd:dateTime; dct:creator ; dct:license ; npx:introduces sub:ITN; prov:wasDerivedFrom . }